The COVID-19 Roller Coaster is a wild ride, strap yourself in and hold on… Cast of Characters: Senator…
On Nov. 26, 2021, the World Health Organization announced that the Technical Advisory Group on SARS-CoV-2 Virus Evolution…
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…
On Nov. 23, 2021, Oxitec announced the successful completion of the mosquito release phase of its landmark project…
On Nov. 22, 2021, Tonix Pharmaceuticals announced the publication of ‘Sangivamycin is highly effective against SARS-CoV-2 in vitro…
On Nov. 22, 2021, Pfizer announced topline results from a longer-term analysis of the safety and efficacy of…
On Nov. 21, 2021, Gavi, the Vaccine Alliance, announced that India has completed the national introduction of pneumococcal…
On Nov. 19, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…
On Nov. 18, 2021, CureVac announced the online publication of the extended preclinical study of the second-generation vaccine…
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
On Nov. 16, 2021, the University of Oxfordﾒs and AstraZeneca announced that two billion doses of the ChAdOx1…
On Nov. 16, 2021, Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working…
On Nov. 15, 2021, AstraZeneca reported that 2 billion doses of the COVID-19 vaccine had been released for…
On Nov. 15, 2021, a large, long-term study of the impacts of COVID-19 on children announced it had…
On Nov. 12, 2021, Regeneron announced that the European Commission (EC) had approved the casirivimab and imdevimab antibody…
On Nov. 12, 2021, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
On Nov. 12, 2021, GlaxoSmithKline and Vir Biotechnology announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase…
On Nov. 12, 2021, Lincoln Children’s Zoo announced on Facebook that their three snow leopards: Ranney, Everest and…
On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…
On Nov. 11, 2021, Roche announced that the European Medicines Agencyﾒs (EMA) Committee for Medicinal Products for Human…
On Nov. 11, 2021, Innovation Pharma reported topline results from the Companyﾒs Phase 2 clinical trial of Brilacidin…
On Nov. 11, 2021, the University of Oxford began recruiting for a Phase I trial to test an…
On Nov. 10, 2021, the Biden-Harris Administration announced that it was increasing access to COVID-19 testing for Americans…
On Nov. 10, 2021, a study by researchers at Georgia State University showed that the politicization of science…
On Nov. 10, 2021, Meridian Bioscience announced that their Revogeneﾮ SARS-CoV-2 assay was granted Emergency Use Authorization by…
On Nov. 9, 2021, Swedish announced a $20 million personal bequest from the late philanthropist Paul G. Allen,…
On Nov. 9, 2021, Howard Hughes Medical Institute announced a program, named Codetta, that can read the genome…
On Nov. 8, 2021, The U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for…
On Nov. 8, 2021, Amyris announced announced it had entered into a 50:50 joint venture arrangement with ImmunityBio…